2012
DOI: 10.1016/j.jvir.2012.04.027
|View full text |Cite
|
Sign up to set email alerts
|

Transarterial Chemoembolization with Drug-eluting Beads Preloaded with Irinotecan as a First-Line Approach in Uveal Melanoma Liver Metastases: Tumor Response and Predictive Value of Diffusion-weighted MR Imaging in Five Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(13 citation statements)
references
References 10 publications
0
13
0
Order By: Relevance
“…Some studies have previously determined the ability of DW-MRI to detect, stage and assess tumor response in oncology (32,33,39,40). Liu et al .…”
Section: Discussionmentioning
confidence: 99%
“…Some studies have previously determined the ability of DW-MRI to detect, stage and assess tumor response in oncology (32,33,39,40). Liu et al .…”
Section: Discussionmentioning
confidence: 99%
“…The pretreatment ADC value of HCC has shown utility in predicting response to cTACE 23,42,51 and DEB-TACE, 52 demonstrating that lower pretreatment ADC values are more likely to respond to cTACE/DEB-TACE. It is postulated that lesions with a high degree of vascularity have more restricted diffusion (ie, lower ADC) making them a more ideal target for intraarterial therapy such as DEB-TACE.…”
Section: Discussionmentioning
confidence: 99%
“…More recently, Venturini et al found an 80% response rate following treatment of five patients with irinotecan (100 mg) drug-eluting beads (100 to 300 µm). 26 One patient achieved a complete response, two patients had a partial response, one patient achieved stable disease, and another patient had progressive disease. Follow-up ranged from 8 to 13 months (mean: 10.6 months), and all patients were alive at last follow-up.…”
Section: Drug-eluting Beadsmentioning
confidence: 93%